Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Thure Meyer who wrote (661)	3/20/1998 2:46:00 PM
From: Rev Paris Green	Read Replies (2) \| Respond to of 1837

It has been my experience with CNBC effects (Joe Kernan Syndrome) is that they are short lived. How many of the new buyers are "investing" in DRMD. How many are speculators. Watch and be careful, because todays gains are too easy. And you know what they say, easy come, easy go... sell, and buy back when sub-$6, probably Monday. IMHO :) p.s. why has DRMD been so cheap for so long. If most people feel that it will get FDA approval at the end of the year, what has prevented it from climbing out of the basement. It is still basically at half of its yearly high. Does DRMD have a skeleton in the closet? ALso, DRMD has a notable short interest. Responses?